Roferon-A, Interferon alfa-2a recombinant, injectable solution 0.5mL

Object Details

Hoffmann-La Roche

Roche Laboratories

Description (Brief): Roferon-A is an injectible, recombinant pharmaceutical used to treat different types of leukemia, malignant melanoma, multiple myeloma, non-Hodgkin's lymphoma, AIDS-related sarcoma, and hepatitis. It was discontinued in October 2007, as new therapies for the diseases it treated were developed.; Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human interferon are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferon, which is harvested and used as the active ingredient in Roferon-A.; Object consists of a sealed white cardboard box with red and black printing. Box contains one multiple-dose vial.
Location: Currently not on view

Physical Description: interferon alfa-2a, recombinant, 3 million IU per 0.5mL (drug active ingredients)
Measurements: overall: 2 11/16 in x 3 1/4 in x 2 in; 6.82625 cm x 8.255 cm x 5.08 cm; overall: 2 3/4 in x 3 1/4 in x 2 in; 6.985 cm x 8.255 cm x 5.08 cm

See more items in: Medicine and Science: Medicine; Health & Medicine; The Antibody Initiative; Biotechnology and Genetics; Recombinant Pharmaceuticals; Science & Mathematics; Antibody Initiative: Monoclonal Antibodies

National Museum of American History

GUID (Link to Original Record): https://n2t.net/ark:/65665/ng49ca746a8-613e-704b-e053-15f76fa0b4fa